SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Ask Michael Burke
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: The Perfect Hedge who wrote (31030)8/13/1998 10:44:00 AM
From: Knighty Tin  Read Replies (2) of 132070
 
Beebs, Isn't this the ONLY thread on SI? -g-

I would not buy calls on bios as they are cheap enough already and timing is real iffy. Here is my current dirty dozen. Scores of former loved bios have appreciated and left the list, such as Incyte, HGSI, Cephalon, etc. This is the current batch:

1. Genzl

2. GZTC

3. LGND

4. Shaman

5. Cell Genysis

6. Medarex

7. Myriad Genetics

8. Sang Stat

9. Chiron

10. Xoma

11. Life Cell

12. Isis Pharm. Yes, I just got back in this one I sold many moons ago because I thought the management was smarmy.

In addition, I own Hambrecht & Quist Life Sciences (HQL). I trade between HQL and HQH when I play my thirds.

One thing to note: The entire biotech list is contained within my capital appreciation portfolio, and the CA portfolio only represents 10 pct. of my total holdings. The 90/10 put program represents 40 pct. and the Maximum Income 50 pct.

MB
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News